LABORATORIOS FARMACEUTOCOS ROVI SA EUR0.06 financial statements, including revenue, expenses, profit, and loss

The total revenue of 0ILL for the last quarter is 234.64 M EUR, and it's 9.63% higher compared to the previous quarter. The net income of Q4 23 is 51.51 M EUR.